Free Trial
OTCMKTS:TSNDF

TerrAscend 3/6/2025 Earnings Report

TerrAscend logo
$0.38 +0.00 (+0.08%)
As of 05/9/2025 03:59 PM Eastern

TerrAscend EPS Results

Actual EPS
$0.01
Consensus EPS
-$0.03
Beat/Miss
Beat by +$0.04
One Year Ago EPS
N/A

TerrAscend Revenue Results

Actual Revenue
$74.35 million
Expected Revenue
$72.37 million
Beat/Miss
Beat by +$1.98 million
YoY Revenue Growth
N/A

TerrAscend Announcement Details

Quarter
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

TerrAscend Earnings Headlines

TerrAscend Reports First Quarter 2025 Financial Results
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
TerrAscend Closes on Ohio Dispensary Acquisition
3 TSX Penny Stocks With Market Caps Over CA$20M
See More TerrAscend Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like TerrAscend? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TerrAscend and other key companies, straight to your email.

About TerrAscend

TerrAscend (OTCMKTS:TSNDF) cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

View TerrAscend Profile

More Earnings Resources from MarketBeat